Escherichia coli ST131 producing CTX-M-15 in Australia
File version
Accepted Manuscript (AM)
Author(s)
Derrington, Petra
Nimmo, Graeme R
Paterson, David L
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Sir, Escherichia coli clonal group ST131 has been reported from many parts of the world and is frequently associated with production of CTX-M-type extended-spectrum β-lactamase (ESBL), in particular CTX-M-15.1,2 Clonal group ST131 may be associated with other β-lactamases or may be resistant to fluoroquinolones; some isolates may be cephalosporin susceptible.3 Thus far, there are no reports of the clonal group ST131 E. coli in Australia. In this study, 49 E. coli clinical isolates resistant to cephalosporins and/or fluoroquinolones collected from six clinical microbiology laboratories in south-east Queensland between 2008 and 2009 were investigated for the presence of this clonal group.
Journal Title
Journal of Antimicrobial Chemotherapy
Conference Title
Book Title
Edition
Volume
65
Issue
6
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2010 Oxford University Press. This is a pre-copyedited, author-produced PDF of an article accepted for publication in Journal of Medical Entomology following peer review. The version of record Escherichia coli ST131 producing CTX-M-15 in Australia, Journal of Medical Entomology, Vol. 65, Issue 6, June 2010, is available online at: https://doi.org/10.1093/jac/dkq098
Item Access Status
Note
Access the data
Related item(s)
Subject
Microbiology
Medical microbiology
Pharmacology and pharmaceutical sciences
Persistent link to this record
Citation
Sidjabat, HE; Derrington, P; Nimmo, GR; Paterson, DL, Escherichia coli ST131 producing CTX-M-15 in Australia, Journal of Antimicrobial Chemotherapy, 2010, 65 (6), pp. 1301-1303